News & Analysis on Clinical Trial Services & Contract Research And Development
PEOPLE ON THE MOVE
By Fiona BARRY
- Last updated on
Leon-Nanodrugs has appointed Theron (Ted) Odlaug as CEO of its German parent company Leon-Nanodrugs GmbH and its newly formed US subsidiary.
The company recently completed a Series A financing round and invested in expanding its service and co-development businesses. The firm offers reformulation help to clients, using nanotechnology to improve the delivery of their small and large molecule drugs.
Odlaug has spent 35 years in biopharmaceuticals, most recently as executive chairman of Cedarburg Pharmaceuticals until its sale to AMRI in 2014. He has also held leadership roles at Planet BioPharmaceuticals, CyDex Pharmaceuticals, EIR Healthcare Advisors, and elsewhere.